Electrotactile display (BrainPort)
DeviceThe BrainPort is a non-surgical assistive device that translates digital information from a video camera to gentle electrotactile stimulation patterns on the surface of the tongue.
NCT Number: NCT07450677
The goal of this clinical investigation is to learn how the brain responds when visual information is converted into patterns of sound or touch in blind and sighted participants. The main questions it aims to answer are:
* Does converting visual information into sound or touch patterns change visual performance in the blind or blindfolded? * How does the brain adapt to different kinds of sensory information?
Researchers will use brain imaging and simple performance tasks to see how people process and learn from this type of converted sensory input. The investigators will compare how individuals with and without long-term vision loss respond to these signals.
Participants will:
* Learn to use technologies to assist in visual information conversion into sound or touch patterns every day for 5 weeks; * Visit the brain imaging center 3 times for brain scans and behavioral tests.
Trial opening soon.
Get Notified8 year–85 year
All sexes
Interventional
Not applicable
Byers Eye Institute at Stanford University, Palo Alto, California, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The BrainPort is a non-surgical assistive device that translates digital information from a video camera to gentle electrotactile stimulation patterns on the surface of the tongue.
The AI Sight is an auditory technology software that can convert visual information into sound patterns, which can be delivered through regular headphones.
Participants will wear the assistive technology system, but there will be no active sensory signals applied.
Time frame: 5 weeks
Measuring the change in the number of correct responses to visual performance tasks from baseline to week 5.
Time frame: 5 weeks
Measuring the change in reaction time to visual performance tasks from baseline to week 5.
Time frame: 5 weeks
Measuring the change in neurometabolic markers by magnetic resonance spectroscopy from baseline to week 5.
Time frame: 5 weeks
Measuring the change in blood-oxygenation-level-dependent brain activity level by T2*-weighted functional magnetic resonance imaging from baseline to week 5.
Time frame: 5 weeks
The change in gray matter density signals from T1-weighted magnetic resonance imaging through 5 weeks
Time frame: 5 weeks
The change in directional diffusivity in the white matter microstructures measured from advanced diffusion magnetic resonance imaging through 5 weeks
Contact information is provided by the study sponsor or research team.
Mariana Nunez, CCRP
CONTACT
Study Team
CONTACT
Stanford University
Other
Neurobehavioral Effects of Visual Assistive Technologies
Acronym: SenSubMRI
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03011541
Abnormalities, Multiple, Age-Related Macular Degeneration
Westport, Connecticut, United States
View Trial DetailsNCT06891443
Blindness, Congenital Abnormalities
San Francisco, California, United States
View Trial DetailsNCT02983370
Blindness, Eye Diseases
Elche, Alicante, Spain
View Trial DetailsNCT07529041
Blindness, Eye Diseases
Göttingen, Germany
View Trial Details